Masakazu Notsu

Advanced Glycation End Products (AGEs), but not High Glucose, Inhibit the Osteoblastic Differentiation of Mouse Stromal ST2 Cells Through the Suppression of Osterix Expression, and Inhibit Cell Growth and Increasing Cell Apoptosis

Kyoko Okazaki, Toru Yamaguchi, Ken-ichiro Tanaka et al. · Calcified Tissue International · 2012 · 96 citations

Osteoblastic Differentiation, Developmental Biology, High Glucose +9

Advanced Glycation End Product 3 (AGE3) Suppresses the Mineralization of Mouse Stromal ST2 Cells and Human Mesenchymal Stem Cells by Increasing TGF-β Expression and Secretion

Masakazu Notsu, Toru Yamaguchi, Kyoko Okazaki et al. · Endocrinology · 2014 · 64 citations · Full text

Primary Aldosteronism as a Risk Factor for Vertebral Fracture

Masakazu Notsu, Mika Yamauchi, Masahiro Yamamoto et al. · The Journal of Clinical Endocrinology & Metabolism · 2017 · 45 citations · Full text

Activation of AMP-activated protein kinase protects against homocysteine-induced apoptosis of osteocytic MLO-Y4 cells by regulating the expressions of NADPH oxidase 1 (Nox1) and Nox2

Ayumu Takeno, Ippei Kanazawa, Ken‐ichiro Tanaka et al. · Bone · 2015 · 41 citations

Inflammation, Nadph Oxidase 1, Signal Transduction +13

Advanced Glycation End Product 3 (AGE3) Increases Apoptosis and the Expression of Sclerostin by Stimulating TGF-β Expression and Secretion in Osteocyte-Like MLO-Y4-A2 Cells

Masakazu Notsu, Ippei Kanazawa, Ayumu Takeno et al. · Calcified Tissue International · 2017 · 30 citations

Sclerostin, Bone Morphogenic Protein, Tgf-β Expression +9